Neuroscientist Alleges Out Irregularities in Alzheimer's Research - Medscape
A US neuroscientist claims that some of the studies of the experimental agent, Simufilam (Cassava Sciences), a drug that targets amyloid beta (Aβ) in Alzheimer's disease (AD), are flawed, and, as...
Read more